1680 East 120th Street, Los Angeles, CA, 90059 · (424) 835-6808
Beds
152
FY 2025
Star rating
4 of 5
Patient survey: 3 of 5
Net patient revenue
$175.2M
FY 2025
Net income
$10.5M
Patient care margin -155.2%
Discharges
9,468
Occupancy 94.1%
Clinicians
298
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $175.2M | $447.1M | -155.2% | $10.5M | 9,468 | $19.0M | 15.1% | 9.1% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 8.1% | US median 8.5% |
| Death rate for heart failure patients | 9.9% | US median 11% |
| Hospital-wide death rate within 30 days | 3.8% | US median 3.9% |
| Death rate for pneumonia patients | 11.7% | US median 15.2% |
| Death rate for stroke patients | 12.7% | US median 11.6% |
| Readmission rate for COPD | 19.8% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $153.4M | $418.3M | -172.6% | -$10.4M | 8,932 | $21.9M | 12.1% | 11.5% |
| 2023 | $142.4M | $410.7M | -188.4% | -$31.4M | 9,098 | $16.1M | 12.8% | 16.5% |
| 2022 | $137.3M | $384.5M | -180.1% | -$20.1M | 9,215 | $21.7M | 12.2% | 11.7% |
| 2021 | $135.8M | $331.8M | -144.4% | $18.5M | 8,656 | $15.6M | 12.3% | 27.4% |
| 2020 | $100.1M | $325.7M | -225.5% | $10.1M | 8,725 | $28.8M | 14.3% | 22.7% |
| US median 19.8% |
| Readmission rate for heart failure | 21.7% | US median 21.3% |
| Readmission rate for pneumonia | 17.5% | US median 17.2% |
| Serious complications (patient safety composite) | 0.92 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.14 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.49 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 0.00 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.00 | US median 0.40 · better |
| Doctors always communicated well | 75% | US median 79% |
| Nurses always communicated well | 71% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 46% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 66% | US median 72% |
| Room and bathroom always clean | 73% | US median 73% |
| Patients who would definitely recommend the hospital | 68% | US median 71% |
| Patients who left the emergency department before being seen | 1% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 150 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 10% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 77% | US median 65% |
| Healthcare workers given the flu vaccine | 95% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 33% | US median 74% |
| 41 |
| $149,138.37 |
| $13,269.12 |
| $7,681.44 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 28 | $181,705.57 | $18,991.14 | $12,400.10 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 27 | $608,603.89 | $55,428.04 | $40,556.82 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 26 | $146,635.42 | $16,567.38 | $10,642.23 |
| DRG 812 RED BLOOD CELL DISORDERS WITHOUT MCC | 25 | $160,376.56 | $11,291.60 | $7,177.67 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 22 | $192,744.86 | $12,658.64 | $7,474.08 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 21 | $196,105.95 | $19,407.05 | $13,076.55 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 21 | $220,222.67 | $19,625.71 | $9,973.97 |
| DRG 603 CELLULITIS WITHOUT MCC | 18 | $179,458.17 | $11,755.22 | $6,446.25 |
| DRG 682 RENAL FAILURE WITH MCC | 17 | $242,350.24 | $18,863.24 | $11,457.18 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 17 | $160,078.71 | $13,545.94 | $7,294.77 |
| DRG 637 DIABETES WITH MCC | 17 | $227,188.12 | $16,173.12 | $11,464.10 |
| DRG 683 RENAL FAILURE WITH CC | 17 | $141,434.59 | $11,985.94 | $6,629.69 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 577 | 489 | $2,664.91 | $2,090.36 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 14 | - | $1,588.14 | $1,219.56 |
| APC 5183 Level 3 Vascular Procedures | 14 | 14 | $3,122.31 | $2,405.01 |
| APC 5182 Level 2 Vascular Procedures | - | - | - | $1,204.32 |
| APC 5191 Level 1 Endovascular Procedures | - | - | - | $2,207.96 |
| APC 5192 Level 2 Endovascular Procedures | - | - | - | $4,338.16 |
| APC 5193 Level 3 Endovascular Procedures | - | - | - | $8,873.86 |
| APC 5194 Level 4 Endovascular Procedures | - | - | - | $14,606.35 |
| APC 5184 Level 4 Vascular Procedures | - | - | - | $3,945.82 |
| APC 5361 Level 1 Laparoscopy and Related Services | - | - | - | $4,357.80 |
| APC 5372 Level 2 Urology and Related Services | - | - | - | $502.15 |
| APC 5373 Level 3 Urology and Related Services | - | - | - | $1,516.28 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Martin Luther King, Jr. Community Hospital is a nonprofit short-term acute care hospital in Los Angeles, CA with 152 beds, part of MLK Community Healthcare and a 4-star overall rating.
Martin Luther King, Jr. Community Hospital in Los Angeles, CA has 152 beds (fiscal year 2025 cost report); 131 beds are certified for Medicare. It discharged 9,468 inpatients that year, with 94.1% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Martin Luther King, Jr. Community Hospital reported net patient revenue of $175.2M and operating expenses of $447.1M, a margin on patient care of -155.2%. After other income and expenses its net income was $10.5M (2.3% of revenue), so it made a profit that year.
Martin Luther King, Jr. Community Hospital is part of MLK Community Healthcare, a health system with 1 hospitals based in Los Angeles, CA. It is a nonprofit hospital.
Martin Luther King, Jr. Community Hospital has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey.
Yes, Martin Luther King, Jr. Community Hospital provides emergency services.
298 Medicare clinicians list Martin Luther King, Jr. Community Hospital as a hospital they work at, most often in Diagnostic Radiology, Internal Medicine, Emergency Medicine.
In 2024, Martin Luther King, Jr. Community Hospital had 667 Medicare inpatient stays in 25 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 148 stays; Medicare paid $23,827.40 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $23K in payments to Martin Luther King, Jr. Community Hospital as a teaching hospital ($23K general and - for research) from 2 companies.